PositiveID, a developer of unique medical devices and molecular diagnostic systems, focuses primarily on diabetes management, rapid medical testing, and airborne bio-threat detection. PositiveID’s wholly owned subsidiary, MFS, focuses on the development of microfluidic systems for automated preparation of and performance of biological assays. PositiveID operates in two main divisions: HealthID and MicroFluidic Systems. For more information visit the company’s Web site at www.PositiveIDCorp.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: